CSBR
Champions Oncology Inc
4.90$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -108.7% | -57.7% | -18.4% | -6.1% | 6.9% | 9.0% | -4.1% | 13.2% | 7.3% | -12.2% | 13.0% | -7.5% | |
| 2.4% | 1.4% | 1.1% | 1.8% | 2.2% | 2.6% | 2.9% | 3.3% | 4.2% | 3.7% | 2.9% | 2.3% | |
| 35.7% | 23.2% | 17.3% | 5.0% | 2.3% | 1.9% | 1.5% | 1.9% | 1.6% | 2.2% | 1.1% | 2.1% | |
| 31.3% | 23.9% | 17.7% | 7.2% | 2.6% | 3.6% | 2.4% | 2.4% | 3.5% | – | – | – | |
| 4.8% | 10.2% | 7.4% | -7.6% | 0.0% | 7.8% | -10.2% | 4.8% | 7.9% | -7.6% | -1.1% | -12.4% | |
| 1.3% | 2.9% | 5.0% | 6.1% | 3.1% | 6.9% | 8.0% | 4.9% | 5.3% | 1.7% | 0.7% | 0.9% | |
| -1.3% | -2.9% | -5.0% | -6.1% | -3.1% | -6.9% | -7.7% | -4.9% | -5.3% | -1.7% | -0.7% | -0.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 0.0% | 0.4% | 28.2% | 0.2% | 5.4% | 13.9% | 3.3% | 0.4% | -0.1% | -1.3% | 0.0% | – | |
| 22.4% | -0.2% | -0.2% | -0.1% | -1.0% | -0.1% | -0.4% | 0.0% | 0.0% | -0.3% | -0.3% | -0.2% | |
| 149.0% | 0.0% | 28.0% | 0.1% | 4.4% | 13.8% | 2.9% | 0.4% | 0.0% | -1.1% | 0.3% | 0.2% | |
| 39.1% | -60.6% | 4.6% | -12.0% | 8.2% | 15.9% | -8.9% | 8.8% | 2.1% | -15.0% | 12.6% | -8.3% | |
| -110.0% | -60.6% | -23.4% | -12.1% | 3.8% | 2.1% | -12.1% | 8.4% | 2.0% | -13.9% | 12.3% | -8.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.